Peter van de Kerkhof

Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis

C.E.M. Griffiths, Bruce Strober, Peter van de Kerkhof et al. · New England Journal of Medicine · 2010 · 851 citations

Medicine, Dermatology, Pharmacotherapy +13

Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials

C.E.M. Griffiths, Kristian Reich, Mark Lebwohl et al. · The Lancet · 2015 · 831 citations

Medicine, Immunology, Pharmacotherapy +10

European S3‐Guidelines on the systemic treatment of psoriasis vulgaris

Delano Pathirana, AD Ormerod, P. Saïag et al. · Journal of the European Academy of Dermatology and Venereology · 2009 · 700 citations · Full text

Medicine, Dermatology, Pharmacotherapy +17

Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council

Bruce Strober, Caitriona Ryan, Peter van de Kerkhof et al. · Journal of the American Academy of Dermatology · 2019 · 243 citations · Full text

Medicine, Dermatology, Dermatopathology +9

High prevalence of foot diseases in Europe: results of the Achilles Project

Tomasz Burzykowski, Geert Molenberghs, Dietrich Abeck et al. · Mycoses · 2003 · 194 citations

Health Professions, Dermatology, Dermatopathology +13